Brief: Curevac Initiates Strategic Restructuring

CureVac NV

03/07/2024 07:15

July 3 (Reuters) - Curevac Nv  5CV.DE :
    * EQS-NEWS: CUREVAC INITIATES STRATEGIC RESTRUCTURING TO
ALIGN
RESOURCES WITH  FOCUS ON HIGH-VALUE MRNA PIPELINE OPPORTUNITIES
    * STRATEGIC RESTRUCTURING INCLUDES A WORKFORCE REDUCTION OF
APPROXIMATELY 30%
    * COMPANY EXPECTS TO DELIVER TWO OR MORE CLINICAL CANDIDATES
BY
END OF 2025
    * PLANS TO INITIATE AT LEAST TWO NEW PHASE 1 STUDIES BY END
OF
2026
    * CASH RUNWAY EXTENDED INTO 2028 THROUGH COMBINATION OF NEW
LICENSING AGREEMENT WITH GSK, REDUCED OPERATING EXPENSES AND
ENHANCED FINANCIAL DISCIPLINE

Source text for Eikon:  ID:nEQ4fpMjLa 
Further company coverage:  5CV.DE 

 ((frankfurt.newsroom@thomsonreuters.com;))